Post your job infront of 100,000+ qualified LP's and GP's.
Recently Filled Jobs
Firms you might be interested in
Posted on: June 21, 2019, 7:06 a.m.
SINGAPORE -- Sinopharm Capital will launch a $150 million investment fund to tap into the growing Southeast Asian healthcare market. The private equity arm of state-owned pharmaceutical giant China National Pharmaceutical Group, Sinopharm Capital will partner with Singapore's Novena Global Lifecare and Chinese private equity firm Cedarlake Capital in the hunt for acquisitions mostly in areas such as ophthalmology and renal care -- as well as new drugs and biomedical projects. Full investment news articleRelevent to this post: MIT Investment Management Company ,